Pediatric maxillofacial infections: a retrospective study of 113 patients.
This is a retrospective review of 113 hospitalized children with maxillofacial infections. The upper face (orbits, paranasal sinuses, maxillary teeth, and cheeks) was affected most frequently in younger children (mean age = 4.03 years), and the source of infection was often unknown. The patients were treated empirically with a second-generation cephalosporin. Lower-face infections (mandibular teeth, submental, sublingual, and submandibular structures) occurred more frequently in older children (mean age = 5.56 years) and were likely to be of odontogenic origin. Empiric therapy in lower face infections usually consisted of penicillin.
Dodson
T B
TB
Department of Oral and Maxillofacial Surgery, University of California, San Francisco 94143.
Perrott
D H
DH
Kaban
L B
LB
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D005145:Face; D005260:Female; D005491:Focal Infection, Dental / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007571:Jaw Diseases / Q000188:drug therapy; D008297:Male; D009059:Mouth Diseases / Q000188:drug therapy; D009333:Neck; D009916:Orbital Diseases / Q000188:drug therapy; D010254:Paranasal Sinus Diseases / Q000188:drug therapy; D012189:Retrospective Studies; D014076:Tooth Diseases / Q000188:drug therapy
D000900:Anti-Bacterial Agents